Compounds > 1,2-dipalmitoylphosphatidylcholine
Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and sirolimus

1,2-dipalmitoylphosphatidylcholine has been researched along with sirolimus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Antonijevic, M; Chowdhry, BZ; Douroumis, D; Lamprou, DA; Onyesom, I; Owusu-Ware, SK; Sygellou, L1
Arami, S; Ghanbarzadeh, S; Khorrami, A; Pourmoazzen, Z1
Arami, S; Ghanbarzadeh, S; Khorrami, A; Mohamed Khosroshahi, L1
Ghanbarzadeh, S; Valizadeh, H; Zakeri-Milani, P1
Douroumis, D; Nandi, U; Onyesom, I1

Other Studies

5 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and sirolimus

ArticleYear
Sirolimus encapsulated liposomes for cancer therapy: physicochemical and mechanical characterization of sirolimus distribution within liposome bilayers.
    Molecular pharmaceutics, 2013, Nov-04, Volume: 10, Issue:11

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Liposomes; Microscopy, Atomic Force; Sirolimus

2013
Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.
    Colloids and surfaces. B, Biointerfaces, 2014, Mar-01, Volume: 115

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Cell Line, Tumor; Cell Proliferation; Cholesterol; Drug Stability; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Oleic Acid; Polyethylene Glycols; Polyvinyls; Sirolimus; Succinates

2014
Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.
    Pharmaceutical biology, 2014, Volume: 52, Issue:7

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibiotics, Antineoplastic; Cell Proliferation; Cholesterol; Dose-Response Relationship, Drug; Drug Stability; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Liposomes; MCF-7 Cells; Particle Size; Phosphatidylethanolamines; Sirolimus; Surface Properties

2014
Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells.
    Drug development and industrial pharmacy, 2015, Volume: 41, Issue:9

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Cholesterol; Drug Liberation; Drug Stability; Humans; Immunosuppressive Agents; Liposomes; Particle Size; Phosphatidylethanolamines; Sirolimus; T-Lymphocytes

2015
An in vitro evaluation of antitumor activity of sirolimus-encapsulated liposomes in breast cancer cells.
    The Journal of pharmacy and pharmacology, 2021, Mar-06, Volume: 73, Issue:3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; 3T3 Cells; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Humans; Liposomes; Mice; Nanoparticles; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sirolimus; Time Factors

2021